Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access               Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain CRL message board posts where the ticker symbol CRL has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest CRL SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-025253 Size: 24 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-025247 Size: 4 KB
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001100682-18-000012 (34 Act)  Size: 10 MB
2018-08-08 001-15943
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001157523-18-001762 (34 Act)  Size: 312 KB
2018-08-08 001-15943
8-K  Documents Current report, item 5.02
Acc-no: 0001299933-18-000600 (34 Act)  Size: 11 KB
2018-08-08 001-15943
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-023857 Size: 12 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-023803 Size: 5 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-023565 Size: 9 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-023473 Size: 4 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-022788 Size: 27 KB
More CRL SEC Filings

Related news from
Thu, 09 Aug 2018
12:01:59 +0000
See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.
Charles River Laboratories International Inc NYSE:CRL
Wed, 08 Aug 2018
12:45:00 +0000
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Charles River Laboratories International, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty ...
Wed, 08 Aug 2018
12:25:12 +0000
Charles River Laboratories (CRL) Beats Q2 Earnings and Revenue Estimates
Charles River (CRL) delivered earnings and revenue surprises of 10.96% and 2.77%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Wed, 08 Aug 2018
11:16:45 +0000
Charles River: 2Q Earnings Snapshot
On a per-share basis, the Wilmington, Massachusetts-based company said it had profit of $1.10. Earnings, adjusted for one-time gains and costs, came to $1.62 per share. The results beat Wall Street expectations. ...
Wed, 08 Aug 2018
11:00:00 +0000
Charles River Laboratories Announces Second-Quarter 2018 Results from Continuing Operations
– Second-Quarter Revenue of $585.3 Million –
Fri, 03 Aug 2018
12:31:12 +0000
Can Tenet Healthcare (THC) Keep Earnings Beat Alive in Q2?
Tenet Healthcare (THC) is likely to repeat its success story in Q2 on the back of a strong performance at the Conifer segment as well as its key initiatives.
Wed, 01 Aug 2018
11:45:00 +0000
Research Report Identifies Myriad Genetics, Celldex Therapeutics, Charles River Laboratories International, Louisiana-Pacific, Integrated Device Technology, and Beazer Homes with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, Aug. 01, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Myriad ...
Wed, 11 Jul 2018
20:33:00 +0000
Charles River Laboratories Schedules Second-Quarter 2018 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (CRL) will release second-quarter 2018 financial results on Wednesday, August 8th, before the market opens. Charles River will host a Meeting with Management on Tuesday, August 14th, from 8:00 a.m. to 12:30 p.m. ET. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts.
Thu, 21 Jun 2018
16:41:55 +0000
A Look At The Fair Value Of Charles River Laboratories International Inc (NYSE:CRL)
How far off is Charles River Laboratories International Inc (NYSE:CRL) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether theRead More...
Fri, 15 Jun 2018
13:23:41 +0000
Charles River Laboratories Is A Leader In Biopharma Outsourcing, KeyBanc Says In Upgrade
Charles River Laboratories Intl. Inc (NYSE: CRL ), a preclinical and clinical laboratory service provider to the pharmaceutical , medical device and biotechnology industries, is "by far" an industry ...
Mon, 04 Jun 2018
20:30:00 +0000
Charles River Laboratories to Present at Jefferies and William Blair Conferences
Charles River Laboratories International, Inc. (CRL) announced today that it will present at the Jefferies 2018 Global Healthcare Conference in New York, New York, on Wednesday, June 6th, at 11:00 a.m. ET, and at the William Blair 38th Annual Growth Stock Conference in Chicago, Illinois, on Wednesday, June 13th, at 10:00 a.m. CT (11:00 a.m. ET). Management will present an overview of Charles River’s strategic focus and business developments. A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at
Tue, 15 May 2018
05:51:34 +0000
Edited Transcript of CRL earnings conference call or presentation 10-May-18 12:30pm GMT
Q1 2018 Charles River Laboratories International Inc Earnings Call
Thu, 10 May 2018
11:00:00 +0000
Charles River Laboratories Announces First-Quarter 2018 Results from Continuing Operations
Charles River Laboratories International, Inc. today reported its results for the first quarter of 2018. For the quarter, revenue from continuing operations was $494.0 million, an increase of 10.8% from $445.8 million in the first quarter of 2017.
Wed, 09 May 2018
13:00:01 +0000
Should You Buy Charles River Laboratories (CRL) Before Earnings?
Charles River Laboratories (CRL) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat.
Thu, 03 May 2018
12:00:00 +0000
Charles River Laboratories Announces Extended Relationship with The Michael J. Fox Foundation
Charles River Laboratories International, Inc. (NYSE: CRL) today announced an extension of its long-standing collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), a leading organization working to support the diagnosis and treatment of Parkinson’s disease (PD). Since 2011, Charles River and MJFF have worked together to accelerate the discovery of therapies for PD. With MJFF support, Charles River has launched a new project, focused on in vivo phenotyping of an α-synuclein knockout model and an α-synuclein A53T knockin model.

"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I have been a VF subscriber for one year and have found the members here generally to be informed, intelligent, articulate people of good will. The knowledge I've gathered has been well worth the price of tuition, and the subscription fee has been repaid many-fold in investment gains." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards